Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Sep 25, 2025

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ROG Roche Holding	CHF 255.00	-2.5%	-5.8%	CHF 218.8b	CHF 297.50	PE23x	E13.7%	3.8%
NOVN Novartis	CHF 98.00	1.3%	0.1%	CHF 189.7b	CHF 99.21	PE17.4x	E8.2%	3.1%
LONN Lonza Group	CHF 518.00	-4.7%	-4.1%	CHF 36.4b	CHF 676.18	PE49.6x	E20.7%	0.8%
GALD Galderma Group	CHF 135.30	-5.9%	71.3%	CHF 32.1b	CHF 141.13	PE106.2x	E32.0%	0.04%
SDZ Sandoz Group	CHF 46.35	-2.1%	30.2%	CHF 20.0b	CHF 49.22	PE109.9x	E27.9%	1.2%
BANB Bachem Holding	CHF 58.15	-10.7%	-18.2%	CHF 4.4b	CHF 74.70	PE32.5x	E17.1%	1.5%
DESN Dottikon ES Holding	CHF 303.00	2.5%	19.5%	CHF 4.2b	CHF 357.63	PE39.7x	S12.7%	0%
SFZN Siegfried Holding	CHF 78.20	-7.6%	-32.7%	CHF 3.4b	CHF 110.07	PE22.2x	E11.0%	0.5%
TECN Tecan Group	CHF 149.40	-5.7%	-45.8%	CHF 1.9b	CHF 220.64	PE30.1x	E16.4%	2.0%
SKAN SKAN Group	CHF 53.50	-7.8%	-32.4%	CHF 1.2b	CHF 82.67	PE74.4x	E28.2%	0.7%
COPN Cosmo Pharmaceuticals	CHF 63.50	-5.6%	-17.3%	CHF 1.0b	CHF 87.81	PE18.1x	E35.2%	3.0%
KURN Kuros Biosciences	CHF 22.74	-4.1%	22.8%	CHF 878.1m	CHF 31.00	PS8.5x	E54.2%	n/a
PPGN PolyPeptide Group	CHF 24.00	-8.0%	-24.1%	CHF 791.8m	CHF 35.60	PS2.3x	E64.9%	0%
IDIA Idorsia	CHF 3.72	-3.9%	123.9%	CHF 777.6m	CHF 4.00	PS3.6x	E29.7%	n/a
BSLN Basilea Pharmaceutica	CHF 46.05	0.9%	-2.2%	CHF 565.8m	CHF 90.62	PE7.8x	E-9.7%	0%
NWRN Newron Pharmaceuticals	CHF 10.50	1.0%	39.6%	CHF 209.6m	CHF 18.04	PE8.9x	E45.2%	n/a
BIOV BioVersys	CHF 28.90	-7.7%	n/a	CHF 168.9m	CHF 60.00	PS129x	E-4.2%	n/a
SANN Santhera Pharmaceuticals Holding	CHF 10.38	-27.5%	16.5%	CHF 134.6m	CHF 30.00	PS2.7x	S53.4%	n/a
XLS Xlife Sciences	CHF 21.00	4.5%	-31.8%	CHF 121.1m	n/a	PE3.9x	n/a	n/a
MOLN Molecular Partners	CHF 2.88	2.1%	-28.0%	CHF 107.7m	CHF 9.25	PS158.1x	E-4.5%	n/a
CURN Curatis Holding	CHF 14.40	-1.4%	91.5%	CHF 71.9m	CHF 84.50	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF 3.00	0.7%	11.1%	CHF 37.8m	n/a	PS9.3x	n/a	n/a
ADXN Addex Therapeutics	CHF 0.066	-2.1%	-8.5%	CHF 6.5m	n/a	PS26.5x	S62.6%	n/a